Browse by author
Lookup NU author(s): Dr Stephen Tuck,
Emeritus Professor Roger Francis
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Osteoporosis is characterised by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and consequent increase in fracture risk. It is a common condition affecting one in three women and one in 12 men, resulting in substantial morbidity, excess mortality, and health and social services expenditure. It is therefore important to develop strategies to prevent and treat osteoporosis in both men and women. This paper reviews the pathogenesis of primary and secondary osteoporosis, as well as diagnosis, investigation, and management. This should include lifestyle changes to reduce bone loss and decrease the risk of falls, the identification and treatment of secondary causes of bone loss, and specific treatment for osteoporosis. Hormone replacement therapy, raloxifene, bisphosphonates, calcium and vitamin D, calcitonin, and parathyroid hormone have all been shown to improve bone density and decrease the risk of fracture in specific situations. it is important that treatment is tailored to the individual patient, to ensure compliance and optimise the potential benefits.
Author(s): Tuck SP, Francis RM
Publication type: Article
Publication status: Published
Journal: Postgraduate Medical Journal
ISSN (print): 0032-5473
Publisher: BMJ Group
Altmetrics provided by Altmetric